Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Four Winning Strategies for Achieving Quality Software in Medical Products
- Medical device, imaging, and information management system companies are faced with ever-increasing pressure to get new products to market faster while continuing to comply with the Quality System Regulation and Design Control requirements. Medical products are long-lived, with most systems lasting 10 years or more. The competitive landscape is fierce,...
- White papers 2004-10-14
- New Product Strategy and Partnership/Acquisition Focus for Medical Products Company
- This $200 million disposable medical device division of an international medical products company faced maturity in its present markets and limited R&D funds to allocate to next-generation products. PRTM was hired to implement an actionable product strategy so the company could realize its dreams of being a major player in...
- Case studies
- Accelerate Market Penetration by Ensuring Your Medical Product's Sellability
- In order to preserve the initial product intent represented by its sellability properties, it is necessary to establish product development strategies that will ensure the fidelity and survival of the sellability properties through the entire development process. This paper explores the importance of designing sellability into a product and verifying...
- White papers 2005-04-26
Additional Resources
- Applied Biosystems Names Lauren Linton, Ph.D., VP, Applications Marketing and Research & Development
- Business Editors & Health/Medical Writers BIOWIRE2K FOSTER CITY, Calif.--BW HealthWire--Oct. 10, 2001 Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, today announced Lauren M. Linton, Ph.D., has been named vice president, Applications Marketing and Research & Development, in the Applications and Products Organization. Linton will have responsibility...
- Research articles 2001-10-10
- Allergan Integrates Inamed's Commercial and Research and Development Operations within New Corporate Division, Allergan Medical
- IRVINE, Calif. -- Allergan, Inc. (NYSE:AGN) today announced it has completed the integration of Inamed's commercial and research and development operations, uniting the companies' facial aesthetics, breast aesthetics and obesity intervention product portfolios under the Allergan name and within a newly established corporate division, Allergan Medical.
- Research articles 2006-10-05
- Herbalife Appoints Luigi Gratton, M.D., M.P.H, Vice President, Medical Affairs and Education
- LOS ANGELES -- Herbalife Ltd. (NYSE:HLF) announces the appointment of Luigi Gratton, M.D., M.P.H., as vice president, medical affairs and education. Dr. Gratton will officially begin July 5, 2005. Dr. Gratton will coordinate the strategic management and direction of Herbalife's Medical Advisory Board MAB, which is chaired by David...
- Research articles 2005-04-18
- Designing medical products for the global economy
- One of the keys to eliminating unnecessary costs in product design is conducting design research early in the development stage. This article is about the designing medical product for global economy. Medical products are particularly sensitive to cultural influence because the differences in medical practices throughout the world are considerable....
- White papers 2000-11-01
- Kellogg's Loffler: Rethinking Biotech and Medical Innovation
- At Kellogg, MBA students are dumping the business casual and donning scrubs in order to learn about medical innovations -- and even create them. Alicia Loffler, director of the Kellogg Center for Biotechnology Management, guides MBAs and other Northwestern students through the real-world struggles of introducing new health-care products....
- Blog posts 2009-02-18
- INC Research Appoints Medical Director of Oncology to European Management Team
- RALEIGH, N.C. -- INC ResearchR, a global contract research organization CRO specialized in oncology, central nervous system CNS, and pediatric clinical research, announced today that Adrian Weiss, M.D., has been appointed as Medical Director of Oncology, Europe. Dr. Weiss will serve as INC Research's senior oncology medical expert in...
- Research articles 2004-11-16
- Patents And New Product Development In The Pharmaceutical And Biotechnology Industries
- The pharmaceutical and biotechnology industries, which are among the most research-intensive industries, have been the focus of several studies on benefit cost and social return on R&D (Research & Development). Elsewhere in this symposium, Frank Lichtenberg has reported on his finding concerning the impact of new drugs on increased longevity,...
- White papers 2005-01-20
- Smiths Medical Appoints Stuart Morris-Hipkins as President of North America
- ROCKLAND, Mass. -- Smiths Medical, the global medical devices manufacturer, announced today that Stuart Morris-Hipkins has been named President, Smiths Medical North America, effective immediately. In his new position, he assumes responsibility for all Sales, Research & Development, Marketing, and Customer Service for all of Smiths-Medical product lines in the...
- Research articles 2008-10-22
- Plexus and SRI International Form Strategic Alliance to Optimize and Accelerate Medical Product Development for Commercialization
- NEENAH, Wis. & MENLO PARK, Calif. -- Plexus Corp. (Nasdaq:PLXS) and SRI International, an independent not-for-profit research institute, have announced an alliance to help medical technology companies bring new leading-edge product solutions to the marketplace. The alliance brings together two world-class organizations: Plexus, a leading "product realization" company and SRI,...
- Research articles 2004-08-23
- Veridien Announces New Product Introductions, Product Line Extensions and Increased Gross Profit Margins; New Initiatives and Priorities in Place for 2002
- Business Editors/Environmental, Health & Medical Writers ST. PETERSBURG, Fla.--BUSINESS WIRE--Nov. 14, 2001 Veridien Corporation (OTCBB:VRDE) today announced five initiatives for the 12 month period beginning January 2002 and a program to have plans in place for those initiatives prior to the end of this calendar year. A decade...
- Research articles 2001-11-14
- Bruker Daltonics Obtains Russian Medical Device Registration for all Flex™-Series MALDI-TOF Mass Spectrometers
- BILLERICA, Mass. and MOSCOW -- Bruker Daltonics Inc. today announces that it has obtained registration of its complete MALDI-TOF product line of microflexTM, autoflexTM TOF or TOF/TOF, and ultraflexTM TOF/TOF mass spectrometers, as well as of its ClinProRobotTM sample preparation platform, as medical devices from the Ministry of Health and...
- Research articles 2006-04-25
- M & M Qualtech UK gives value-added service.(Design and research and development)
- Qualtech, a service provider to the medical and electronics industries, underscored its commitment to the medical industry when it updated its quality system by achieving ISO 13485. Its offering ranges from project management, new product introduction and design for manufacturing, through to order fulfilment and distribution...
- Research articles 2005-01-01
- Sectra Widens Its Product Offering Through New Partnership; Sectra and Research Systems Sign Clinical Solutions Agreement
- Business Editors & Technology Writers STOCKHOLM, Sweden--BUSINESS WIRE--Nov. 21, 2001 The Swedish IT and medical technology company Sectra has signed a clinical solutions agreement with the US-based company Research Systems regarding the integration of Watsyn. Watsyn provides rapid application development capabilities for Sectra's system for digital radiology. ...
- Research articles 2001-11-21
- New Findings in Stem Cell Cultivation and Lymphoma Vaccine Development Are Highlighted at American Society of Hematology Conference
- Business Editors/Health & Medical Writers American Society of Hematology Conference ORLANDO, Fla.--BW HealthWire--Dec. 11, 2001 At the 43rd Annual Meeting and Exposition of the American Society of Hematology ASH, Large Scale Biology Corporation (Nasdaq: LSBC) reported scientific news in three important areas: cancer vaccines, stem cell biology...
- Research articles 2001-12-11
- HemCon Bandage Receives 2004 ''Top 10 Greatest Inventions'' Award from U.S. Army; Life-Saving Bandage Recognized for Innovative Technology and Impact on Army Capabilities
- PORTLAND, Ore. -- HemCon Inc., an industry leader in hemorrhage control technology, announced today that the U.S. Army has named the HemConR Bandage as one of the 2004 "Top 10 Greatest Inventions." The awards, given annually by the U.S. Army Research, Development and Engineering Command, recognize the best new technology...
- Research articles 2005-05-31
- BioSource International signs letter of intent to acquire Operon Technologies, Inc.; Acquisition of privately-held synthetic DNA manufacturer in Alameda, Calif. would add complementary product lines, significantly increase revenue base
- CAMARILLO, Calif.,--BUSINESS WIRE--May 5, 1995--BioSource International, Inc. (NASDAQ:BIOI) today announced that it has signed a letter of intent to acquire Operon Technologies, Inc., a privately-held firm headquartered in Alameda, Calif., that develops and sells oligonucleotides DNA segments and other custom biochemical products used as reagents in biochemistry and immunology research,...
- Research articles 1995-05-05
- Becton Dickinson F3Q07 (Qtr End 6/30/07) Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions And we'll go to the line of Mike Weinstein from J.P. Morgan. Please go ahead. Mike Weinstein - J.P. Morgan Thank you for taking the questions, good morning. I'd like to start on the MRSA opportunity, I think on our last update, you'd commented that...
- Earnings calls 2007-07-26
- << Previous
- page 1 of 1
- Next >>
Presented by American Express